Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014903 |
| CAS No | NA |
| Mol.F. | C30H23Cl2N7O |
| Mol.Wt. | 568.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014904 |
| CAS No | NA |
| Mol.F. | C30H22Cl2N8O2 |
| Mol.Wt. | 597.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014905 |
| CAS No | NA |
| Mol.F. | C18H20ClN5O2 |
| Mol.Wt. | 373.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014906 |
| CAS No | NA |
| Mol.F. | C18H13F4N3O5S |
| Mol.Wt. | 459.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014907 |
| CAS No | NA |
| Mol.F. | C15H16BrN3O |
| Mol.Wt. | 334.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014908 |
| CAS No | NA |
| Mol.F. | C16H18N2O5 |
| Mol.Wt. | 318.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014909 |
| CAS No | 55557-00-1 |
| Mol.F. | C5H10N4O2 |
| Mol.Wt. | 158.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014910 |
| CAS No | 50270-42-3 |
| Mol.F. | C11H14N2O3 |
| Mol.Wt. | 222.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014911 |
| CAS No | 37620-20-5 |
| Mol.F. | C10H13N3O |
| Mol.Wt. | 191.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014912 |
| CAS No | 75195-76-5 |
| Mol.F. | C9H11N3O2 |
| Mol.Wt. | 193.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014913 |
| CAS No | NA |
| Mol.F. | C9H12N2O4 |
| Mol.Wt. | 212.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014914 |
| CAS No | NA |
| Mol.F. | C9H12N2O4 |
| Mol.Wt. | 212.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014915 |
| CAS No | NA |
| Mol.F. | C9H12N2O6S |
| Mol.Wt. | 276.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014916 |
| CAS No | NA |
| Mol.F. | C22H17FN8O2 |
| Mol.Wt. | 444.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014917 |
| CAS No | NA |
| Mol.F. | C9H10N2O4 |
| Mol.Wt. | 210.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014918 |
| CAS No | NA |
| Mol.F. | C29H30N8O2 |
| Mol.Wt. | 522.6 |
| INV STATUS | CUSTOM SYNTHESIS |